1. Home
  2. ASND vs WYNN Comparison

ASND vs WYNN Comparison

Compare ASND & WYNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASND
  • WYNN
  • Stock Information
  • Founded
  • ASND 2006
  • WYNN 2002
  • Country
  • ASND Denmark
  • WYNN United States
  • Employees
  • ASND N/A
  • WYNN N/A
  • Industry
  • ASND Biotechnology: Pharmaceutical Preparations
  • WYNN Hotels/Resorts
  • Sector
  • ASND Health Care
  • WYNN Consumer Discretionary
  • Exchange
  • ASND Nasdaq
  • WYNN Nasdaq
  • Market Cap
  • ASND 12.0B
  • WYNN 11.6B
  • IPO Year
  • ASND 2015
  • WYNN 2002
  • Fundamental
  • Price
  • ASND $204.05
  • WYNN $123.66
  • Analyst Decision
  • ASND Strong Buy
  • WYNN Strong Buy
  • Analyst Count
  • ASND 16
  • WYNN 14
  • Target Price
  • ASND $240.75
  • WYNN $128.64
  • AVG Volume (30 Days)
  • ASND 401.5K
  • WYNN 1.7M
  • Earning Date
  • ASND 11-13-2025
  • WYNN 11-06-2025
  • Dividend Yield
  • ASND N/A
  • WYNN 0.81%
  • EPS Growth
  • ASND N/A
  • WYNN N/A
  • EPS
  • ASND N/A
  • WYNN 3.40
  • Revenue
  • ASND $576,332,355.00
  • WYNN $6,970,314,000.00
  • Revenue This Year
  • ASND $102.31
  • WYNN $0.55
  • Revenue Next Year
  • ASND $76.44
  • WYNN $4.31
  • P/E Ratio
  • ASND N/A
  • WYNN $36.40
  • Revenue Growth
  • ASND 54.50
  • WYNN N/A
  • 52 Week Low
  • ASND $118.03
  • WYNN $65.25
  • 52 Week High
  • ASND $208.16
  • WYNN $134.23
  • Technical
  • Relative Strength Index (RSI)
  • ASND 60.82
  • WYNN 48.70
  • Support Level
  • ASND $187.25
  • WYNN $127.81
  • Resistance Level
  • ASND $205.48
  • WYNN $134.23
  • Average True Range (ATR)
  • ASND 5.42
  • WYNN 3.99
  • MACD
  • ASND 0.41
  • WYNN -0.34
  • Stochastic Oscillator
  • ASND 92.16
  • WYNN 24.72

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

About WYNN Wynn Resorts Limited Common stock

Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively. In 2024, both the US and Macao were each 50% of total EBITDA.

Share on Social Networks: